Reviva Pharmaceuticals I...

NASDAQ: RVPH · Real-Time Price · USD
0.82
0.02 (2.50%)
At close: Jun 06, 2025, 3:59 PM
0.84
2.84%
After-hours: Jun 06, 2025, 05:15 PM EDT

Reviva Pharmaceuticals Statistics

Share Statistics

Reviva Pharmaceuticals has 46.74M shares outstanding. The number of shares has increased by 56.22% in one year.

46.74M
56.22%
0%
22.87%
n/a
108
0.02%

Short Selling Information

The latest short interest is 3.04M, so 6.51% of the outstanding shares have been sold short.

3.04M
6.51%
7.54%
8.12

Valuation Ratios

The PE ratio is -2.01 and the forward PE ratio is -1.22. Reviva Pharmaceuticals's PEG ratio is 0.04.

-2.01
-1.22
0
0.1
73.84
-1.79
0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Reviva Pharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.56.

1.01
1.01
0.56
-0.02
-0.01
-1665.07

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-2,137,057.29
14
0
n/a

Taxes

19.51K
-0.07%

Stock Price Statistics

The stock price has increased by -43.06% in the last 52 weeks. The beta is 0.11, so Reviva Pharmaceuticals's price volatility has been higher than the market average.

0.11
-43.06%
0.82
1.28
44.97
679,888

Income Statement

n/a
n/a
-30.8M
-29.92M
-29.88M
-29.88M
-0.9
Full Income Statement

Balance Sheet

The company has 13.48M in cash and 458.15K in debt, giving a net cash position of 13.02M.

13.48M
458.15K
13.02M
-164.27M
15.5M
81.86K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -33.54M and capital expenditures 0, giving a free cash flow of -33.54M.

-33.54M
n/a
-33.54M
-1.01
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

RVPH does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for RVPH is $9, which is 997.6% higher than the current price. The consensus rating is "Buy".

$9
997.6%
Buy
6
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-17.87
0